These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1099 related articles for article (PubMed ID: 34606227)

  • 1. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
    Han J; Du Z; Lim MH
    Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minor Structural Variations of Small Molecules Tune Regulatory Activities toward Pathological Factors in Alzheimer's Disease.
    Beck MW; Derrick JS; Suh JM; Kim M; Korshavn KJ; Kerr RA; Cho WJ; Larsen SD; Ruotolo BT; Ramamoorthy A; Lim MH
    ChemMedChem; 2017 Nov; 12(22):1828-1838. PubMed ID: 28990338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, and Biological Evaluation of Ferulic Acid-Piperazine Derivatives Targeting Pathological Hallmarks of Alzheimer's Disease.
    Singh G; Kumar S; Panda SR; Kumar P; Rai S; Verma H; Singh YP; Kumar S; Srikrishna S; Naidu VGM; Modi G
    ACS Chem Neurosci; 2024 Aug; 15(15):2756-2778. PubMed ID: 39076038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Strategies for Modulating Aβ Aggregation with Multifunctional Agents.
    Du Z; Li M; Ren J; Qu X
    Acc Chem Res; 2021 May; 54(9):2172-2184. PubMed ID: 33881820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diosmetin derivatives as multifunctional anti-AD ligands: Design, synthesis, and biological evaluation.
    Yang A; Yi X; Zhang H; Shen R; Kou X
    Chem Biol Drug Des; 2024 Apr; 103(4):e14529. PubMed ID: 38670598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuning Structures and Properties for Developing Novel Chemical Tools toward Distinct Pathogenic Elements in Alzheimer's Disease.
    Han J; Lee HJ; Kim KY; Lee SJC; Suh JM; Cho J; Chae J; Lim MH
    ACS Chem Neurosci; 2018 Apr; 9(4):800-808. PubMed ID: 29283241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of oxidative stress and other pathologies in Alzheimer's disease.
    Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
    Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological evaluation and molecular modeling of benzofuran piperidine derivatives as Aβ antiaggregant.
    Chowdhury SR; Gu J; Hu Y; Wang J; Lei S; Tavallaie MS; Lam C; Lu D; Jiang F; Fu L
    Eur J Med Chem; 2021 Oct; 222():113541. PubMed ID: 34116326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties.
    Cai P; Fang SQ; Yang HL; Yang XL; Liu QH; Kong LY; Wang XB
    Eur J Med Chem; 2018 Sep; 157():161-176. PubMed ID: 30096650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimalistic Principles for Designing Small Molecules with Multiple Reactivities against Pathological Factors in Dementia.
    Kim M; Kang J; Lee M; Han J; Nam G; Tak E; Kim MS; Lee HJ; Nam E; Park J; Oh SJ; Lee JY; Lee JY; Baik MH; Lim MH
    J Am Chem Soc; 2020 May; 142(18):8183-8193. PubMed ID: 32233474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel salicylamide derivatives as potent multifunctional agents for the treatment of Alzheimer's disease: Design, synthesis and biological evaluation.
    Song Q; Li Y; Cao Z; Qiang X; Tan Z; Deng Y
    Bioorg Chem; 2019 Mar; 84():137-149. PubMed ID: 30500523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of novel tacrine-dipicolylamine dimers that are multiple-target-directed ligands with potential to treat Alzheimer's disease.
    Zhang P; Wang Z; Mou C; Zou J; Xie Y; Liu Z; Benjamin Naman C; Mao Y; Wei J; Huang X; Dong J; Yang M; Wang N; Jin H; Liu F; Lin D; Liu H; Zhou F; He S; Zhang B; Cui W
    Bioorg Chem; 2021 Nov; 116():105387. PubMed ID: 34628225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-mechanism-based engineering of chemical regulators targeting distinct pathological factors in Alzheimer's disease.
    Beck MW; Derrick JS; Kerr RA; Oh SB; Cho WJ; Lee SJ; Ji Y; Han J; Tehrani ZA; Suh N; Kim S; Larsen SD; Kim KS; Lee JY; Ruotolo BT; Lim MH
    Nat Commun; 2016 Oct; 7():13115. PubMed ID: 27734843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and evaluation of chalcone-Vitamin E-donepezil hybrids as multi-target-directed ligands for the treatment of Alzheimer's disease.
    Sang Z; Song Q; Cao Z; Deng Y; Zhang L
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):69-85. PubMed ID: 34894968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Multifunctional Pyrimidinylthiourea Derivatives as Potential Anti-Alzheimer Agents.
    Li X; Wang H; Lu Z; Zheng X; Ni W; Zhu J; Fu Y; Lian F; Zhang N; Li J; Zhang H; Mao F
    J Med Chem; 2016 Sep; 59(18):8326-44. PubMed ID: 27552582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer's disease.
    Wichur T; Więckowska A; Więckowski K; Godyń J; Jończyk J; Valdivieso ÁDR; Panek D; Pasieka A; Sabaté R; Knez D; Gobec S; Malawska B
    Eur J Med Chem; 2020 Feb; 187():111916. PubMed ID: 31812794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Liu T; Chen S; Du J; Xing S; Li R; Li Z
    Eur J Med Chem; 2022 Jan; 227():113973. PubMed ID: 34752955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
    Zha GF; Zhang CP; Qin HL; Jantan I; Sher M; Amjad MW; Hussain MA; Hussain Z; Bukhari SN
    Bioorg Med Chem; 2016 May; 24(10):2352-9. PubMed ID: 27083471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromone-lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities.
    Jalili-Baleh L; Nadri H; Forootanfar H; Küçükkılınç TT; Ayazgök B; Sharifzadeh M; Rahimifard M; Baeeri M; Abdollahi M; Foroumadi A; Khoobi M
    Daru; 2021 Jun; 29(1):23-38. PubMed ID: 33420969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.